Dr Reddy’s Laboratories

NPPA fixes retail prices for 14 formulations

Read more

Expect to launch 25 products in US this fiscal: Dr Reddy’s

Read more

Dr Reddy’s Laboratories launch Abiraterone Acetate Tablets USP in the US

Read more

Centre clarifies reasons for delay in approvals for remdesivir

Read more

Dr Reddy’s signs licensing agreement with Gilead Sciences for remdesivir

Read more

Dr Reddy’s announces launch of Colchicine Tablets USP in the US

Read more

Dr Reddy’s Laboratories completes acquisition of Wockhardt’s select business divisions

Read more

Dr Reddy’s PAT up 76 per cent in Q4, soft-launches HCQ in India

Read more

Dr Reddy’s recalls its heart burn medicine in the US

Read more

Dr Reddy’s gets EIR from USFDA for Srikakulam plant

Read more